Portage biotech announces completion of $2.15 million private financing

Dover, del., jan. 30, 2025 (globe newswire) -- portage biotech, inc. (“portage” or the “company”) (nasdaq: prtg), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced that it has completed a private placement of $2.15 million from two portage directors.
ATON Ratings Summary
ATON Quant Ranking